Pay in 4 interest-free payments of $7.32 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
The results support that tirzepatide leads to substantial weight reduction and constitutes a valuable therapeutic option for weight management, despite an increase in gastrointestinal symptoms
This reflects a strong preference for in-person care and ongoing medical oversight
Tirzepatide (Zepbound and Mounjaro): weekly vials you load into a syringe yourself or preloaded injection pens Semaglutide (Wegovy and Ozempic): weekly, preloaded injection pen in various doses Liraglutide (Saxenda and Victoza): daily injectable pens Other GLP-1s and weight-loss meds: Trulicity , a less common GLP-1 (dulaglutide), comes in the form of a pen for once-weekly injections Bydureon BCise (once-weekly preloaded injection) Rybelsus (oral method) Contrave and Xenical (weight-loss drugs that are not GLP-1s and typically come at a much cheaper price tag) Other medications: antibiotics, antidepressants, asthma medication, and much, much more Note: Ozempic, Mounjaro, Victoza, Trulicity, Bydureon, and Rybelsus are FDA approved for type 2 diabetes only and must be prescribed off-label for use as a weight-loss treatment
Afshar-Oromieh, A
" Fat loss made easy with personalized GLP-1 medication " - means the enrollment process is digital and convenient (no office visit, no insurance required)
It is mainly used to treat certain digestive conditions, not obesity
